​

Funding Round

Series A - Myo

Series A - Myo

Investment Firm

Overview

Myo Is a communication platform for nursing homes.

Announced Date

Jan 31, 2024

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

TVM Capital Life Science

TVM Capital Life Science

TVM Capital Life Science is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

10

Investor Name
Participant InvestorBonVenture
Participant InvestorTVM Capital Life Science
Participant InvestorCarpediem Capital
Participant InvestorAxel Springer Plug and Play Accelerator
Participant InvestorMountain Partners

Round Details and Background

Myo raised $8643565 on 2024-01-31 in Series A

Myo Is a communication platform for nursing homes.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 17, 2018
Seed Round - Myo
1-1.7M
Mar 01, 2019
Non Equity Assistance - Myo
1-undefined
Oct 25, 2020
Seed Round - Myo
5-3.6M
Jan 31, 2024
Series A - Myo
10-8.6M

Recent Activity

There is no recent news or activity for this profile.